oncogene-driven metastatic nsclc: frontline treatment & resistance mechanisms - onctalk 2022
Published 1 year ago • 62 plays • Length 6:20Download video MP4
Download video MP3
Similar videos
-
7:35
current treatments for oligometastatic nsclc - lung cancer onctalk 2022
-
6:58
strategies to overcome resistance - lung cancer onctalk 2022
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
8:03
studies in anti-pd-l1 monotherapy for nsclc - lung cancer onctalk 2022
-
2:18
treatment of stage iv nsclc with high pd-l1 and atypical mutation - lung cancer onctalk 2022
-
6:40:28
full video ondemand -targeted therapies patient forum 2022 - for those living with lung cancer
-
1:44
extended interval dosing for pembrolizumab - lung cancer onctalk 2022
-
0:58
dr. shum on mechanisms of resistance in oncogene-driven nsclc
-
4:56
dual immune checkpoint blockade with or without chemotherapy - lung cancer onctalk 2022
-
4:29
studies in chemoimmunotherapy - lung cancer onctalk 2022
-
3:25
checkmate 816: neoadjuvant nivolumab chemotherapy for nsclc - onctalk lung 2023
-
2:00
keynote 671: perioperative pembrolizumab for nsclc - onctalk lung 2023
-
2:32
segmentectomy for early stage nsclc - onctalk lung 2023
-
3:14
stereotactic body radiotherapy (sbrt) for oligoprogressive nsclc - onctalk lung 2023
-
22:46
mechanisms of alk resistance & implications for treatment
-
33:47
gracecast-049_lung-cancer_weiss on egfr therapy for early stage nsclc
-
2:11
treating side effects from neoadjuvant chemoimmunotherapy - lung cancer onctalk 2022